CoreCap Advisors’s Tandem Diabetes Care TNDM Stock Holding History

CoreCap Advisors’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$19K	Hold	1,164	–	–	﹤0.01%	1817
2026 Q2	$17.6K	Sell	1,164 -119	-9%	-$2.08K	﹤0.01%	1854
2026 Q1	$24.6K	Sell	1,283 -4,626	-78%	-$101K	﹤0.01%	1591
2025 Q4	$130K	Buy	5,909 +1,158	+24%	+$20.9K	﹤0.01%	938
2025 Q3	$57.7K	Buy	4,751 +3,468	+270%	+$46.9K	﹤0.01%	1258
2025 Q2	$23.9K	Hold	1,283	–	–	﹤0.01%	1540
2025 Q1	$24.6K	Hold	1,283	–	–	﹤0.01%	1454
2024 Q4	$46.2K	Hold	1,283	–	–	﹤0.01%	1213
2024 Q3	$54.4K	Buy	+1,283	New	+$54.4K	﹤0.01%	1149
2024 Q2	–	Sell	-1,053	Closed	-$37.3K	–	2488
2024 Q1	$37.3K	Buy	+1,053	New	+$28.2K	﹤0.01%	1226
2022 Q4	$49.7K	Buy	+1,106	New	+$50.1K	﹤0.01%	990
2022 Q3	–	Sell	-1,032	Closed	-$61K	–	1949
2022 Q2	$61K	Buy	+1,032	New	+$84.7K	﹤0.01%	875
2022 Q1	–	Sell	-1,432	Closed	-$216K	–	1952
2021 Q4	$216K	Buy	+1,432	New	+$193K	0.01%	520

Other funds holding TNDM

Paradice Investment Management Denver, Colorado $594M AUM 28.38% 1-Year Est. Return

Inspire Investing Meridian, Idaho $2.37B AUM 29.82% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Banque Pictet & Cie Geneva 73, Switzerland $14.5B AUM 33.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Fideuram - Intesa Sanpaolo Private Banking Turin $3.5B AUM 45.13% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return

Amalgamated Bank New York $14.3B AUM 35.81% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.87B AUM 34.1% 1-Year Est. Return

CoreCap Advisors's TNDM Position: Q3 2026 in Review

CoreCap Advisors held its Tandem Diabetes Care (TNDM) position steady in Q3 2026 at 1,164 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1817.

CoreCap Advisors first reported a position in TNDM in Q4 2021 and has held it in 13 quarters since. The position peaked at $216K in Q4 2021. 37 funds tracked by Wall St. Rank hold TNDM as of Q3 2026.

CoreCap Advisors held 1,164 shares of Tandem Diabetes Care worth $19K as of Q3 2026.
CoreCap Advisors left its Tandem Diabetes Care share count unchanged in Q3 2026.
Tandem Diabetes Care made up ﹤0.01% of CoreCap Advisors's portfolio in Q3 2026, its #1817 holding.
CoreCap Advisors first reported a position in Tandem Diabetes Care in Q4 2021 and has held it in 13 quarters since.
CoreCap Advisors's Tandem Diabetes Care position peaked at $216K in Q4 2021.
37 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.